Skip to content

Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)

Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05024708
Acronym
CA2VD
Enrollment
60
Registered
2021-08-27
Start date
2023-01-16
Completion date
2024-01-16
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmogenic Right Ventricular Cardiomyopathy

Keywords

ARVC, Athlete's heart, exercise, CMR, RV contractile reserve

Brief summary

Prospective, nonrandomized, single-center, comparative study to define if right ventricular (RV) contractile reserve assessed by exercise CMR helps to improve the differential diagnosis between pathological and physiological remodeling of the RV; ie. arrhythmogenic right ventricular cardiomyopathy (ARVC) and athlete's heart.

Detailed description

Comparison of the RV contractile reserve in 4 groups of patients: Arrhythmogenic right ventricular cardiomyopathy (ARVC) patients; endurance athletes with a dilated RV, endurance athletes with normal RV, untrained subject with normal RV. Patients will come to the hospital for 3 visits (3 half days): * Visit 1: clinical evaluation, rest ECG, rest echocardiography, cardio-pulmonary exercise test. * Visit 2: exercise echocardiography, holter ECG monitor (48 yours) * Visit 3: rest CMR and exercise CMR (ergocycle)

Interventions

OTHERCardiac exercises and tests

Rest ECG, rest echocardiography, cardio-pulmonary exercise test, exercise echocardiography, holter ECG monitor (48 yours), rest CMR, exercise CMR (ergocycle)

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men or women aged 18 years and older, * patients with confirmed ARVC, but with no major RV dysfunction (RVEF \>40%) * endurance athletes with dilated RV * endurance athletes with non-dilated RV * untrained healthy subjects with non-dilated RV * who signed a written free and informed consent:

Exclusion criteria

* Patients with other cardiovascular disease; * Contra-indication to CMR (in particular presence of a non-CMR compatible implantable cardiac defibrillator); * Patients with permanent supraventricular arrhythmia; * Patients unable to perform an exercise test on an ergocycle; * Person subject to legal protection (safeguard justice, trusteeship and guardianship) and persons deprived of liberty

Design outcomes

Primary

MeasureTime frame
Evolution of right ventricular ejection fraction (RVEF) assessed with CMR during exerciseThrough study completion, an average of 1 month

Secondary

MeasureTime frame
Evolution of Tricuspid annular plane systolic excursion (TAPSE) during exerciseThrough study completion, an average of 1 month
Evolution of S' tricuspid wave during exerciseThrough study completion, an average of 1 month
Evolution of RV fractional area during exerciseThrough study completion, an average of 1 month
Evolution of free wall RV strain during exerciseThrough study completion, an average of 1 month

Countries

France

Contacts

Primary ContactFrédéric SCHNELL, MD-PhD
Frederic.SCHNELL@chu-rennes.fr+33 2.99.28.41.33

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026